Valuation: GI Dynamics, Inc.

Market Cap 440K 393K 367K 333K 627K 42.66M 633K 4.41M 1.72M 21.68M 1.65M 1.62M 69.72M P/E 2019
-1.12x
P/E 2020 -0.03x
Enterprise Value 3.28M 2.93M 2.73M 2.48M 4.67M 318M 4.72M 32.8M 12.83M 161M 12.31M 12.05M 519M EV / Sales 2019
-
EV / Sales 2020 -
Free-Float
-
Yield 2019 *
-
Yield 2020 -
Manager TitleAgeSince
Chief Executive Officer - 04/08/2025
Director of Finance/CFO 57 31/07/2025
Chief Tech/Sci/R&D Officer - 31/03/2023
Director TitleAgeSince
Director/Board Member - 19/10/2020
Director/Board Member - -
Director/Board Member 69 30/09/2023

Financials

2019 2020
Net sales - -
Net income -17.33M -15.48M -14.44M -13.12M -24.68M -1.68B -24.92M -173M -67.81M -853M -65.08M -63.67M -2.74B -11.14M -9.94M -9.28M -8.43M -15.86M -1.08B -16.01M -111M -43.56M -548M -41.81M -40.9M -1.76B
Net Debt 2.89M 2.58M 2.41M 2.18M 4.11M 280M 4.15M 28.88M 11.29M 142M 10.84M 10.6M 457M 2.84M 2.54M 2.37M 2.15M 4.04M 275M 4.08M 28.4M 11.11M 140M 10.66M 10.43M 449M
Logo GI Dynamics, Inc.
GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.
Employees
-
Sector
-